LIVEN: Lifestyle Management App for Adults With Diabetes Type

Sponsor
Princess Nourah Bint Abdulrahman University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05630508
Collaborator
Liven (Other)
90
1
3
27
3.3

Study Details

Study Description

Brief Summary

This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: interactive Mhealth Lifestyle behavior intervention
  • Other: Sham
N/A

Detailed Description

This study will investigate the feasibility of a 12-weeks online lifestyle (nutrition and physical behavior) coaching program through a mobile app (LIVEN) compared to standard treatment for people with type 2 diabetes. This study will be done in two phases; the first phase is the usability study (phase1), in which the user friendliness of the application will be assessed, and any technical flaws will be resolved prior and during the second phase. The second phase of the study will consist of adapting a diabetes educational material and assessing the feasibility of the program (phase2). the investigators hypothesize that the 12-week online lifestyle-coaching program will be feasible, and a full-scale study can proceed.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are assigned to one of three groups in parallel for the duration of the studyParticipants are assigned to one of three groups in parallel for the duration of the study
Masking:
Single (Participant)
Masking Description:
The participant won't know if they got the full or sham or no intervention
Primary Purpose:
Supportive Care
Official Title:
mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study
Actual Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: interactive mhealth Lifestyle behavior intervention

Receiving Standard care, LIVEN educational material and interactive LIVEN application

Behavioral: interactive Mhealth Lifestyle behavior intervention
Receiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months

Sham Comparator: Sham group - app access only

Receiving standard care, LIVEN educational material and access to the application

Other: Sham
Receiving standard care, LIVEN educational material and access to the application

No Intervention: Control group - Standard care

Receiving Standard care only

Outcome Measures

Primary Outcome Measures

  1. recruitment rate - descriptive [immediately after the intervention (3 months)]

    reported as the number of participants' consented divide by the number of people that were invited to participate

  2. retention rates [immediately after the intervention (3 months)]

    reported as the number of participants completing all study sessions

  3. User friendliness [Daily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.]

    will be assessed via user engagement tracking in the app

Secondary Outcome Measures

  1. Glycemic control - A1c [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assess via A1c blood test will be reported as percentage. higher % indicate worse outcome

  2. Glycemic control - continuous glucose mentoring (CGM) [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assess via continuous glucose mentoring (CGM) as variability. higher variability indicates worse outcome

  3. Body composition - fat free mass (%) physiological parameter [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assessed via Bioelectrical Impedance Analysis (BIA). fat free mass (%) will reported as percentage. higher % indicate better outcome

  4. Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire) [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assessed via Health-Promoting Lifestyle profile II. HPLP-II is a 4-point Likert scale with 52 items including six subscales: health responsibility, physical activity, nutrition, spiritual growth, interpersonal relationships, and stress management. scores range from 52 to 208. higher scores indicate better outcome.

  5. physical performance assessments - upper body muscle strength in kg [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assessed via Hand Grip Strength using dynameter (power in kg), higher scores indicate higher physical performance

  6. physical performance assessments - lower body muscle strength in counts [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assessed via Sit to Stand Test (count), higher counts indicate higher physical performance

  7. physical performance assessments - endurance [will be assessed one week prior to the intervention and one week after the end of the intervention]

    will be assessed via 6-minute walk test (distance in m). higher distance indicates higher endurance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults, aged 18 years or older

  • Arabic speakers

  • Capable of utilizing smartphones

  • Diagnosed with T2DM

  • Poor glycemic control: A1c > 7.5%

Exclusion Criteria:
  • Individuals using insulin injection

  • Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease)

  • Women who are pregnant or breastfeeding

  • Individuals diagnosed with other types of diabetes (such as type I or MODY)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Princess Nourah bint Abdulrahman University Riyadh Saudi Arabia 11321

Sponsors and Collaborators

  • Princess Nourah Bint Abdulrahman University
  • Liven

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shaima Alothman, Research Scientist, Clinical Assistant Professor, Princess Nourah Bint Abdulrahman University
ClinicalTrials.gov Identifier:
NCT05630508
Other Study ID Numbers:
  • 22-0140
First Posted:
Nov 29, 2022
Last Update Posted:
Nov 29, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shaima Alothman, Research Scientist, Clinical Assistant Professor, Princess Nourah Bint Abdulrahman University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 29, 2022